Share on LinkedInShare on LinkedIn

ARTICLE · 22 APRIL 2020

Congress Passes Coronavirus Stimulus Bill

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Last week, the United States Congress passed the Coronavirus Stimulus Bill. The Bill gives the USPTO the authority to "toll, waive, adjust, or modify, ...

United StatesCoronavirus (COVID-19)

Last week, the United States Congress passed the Coronavirus Stimulus Bill. The Bill gives the USPTO the authority to “toll, waive, adjust, or modify, any timing deadline” as appropriate if the President’s declaration of emergency in response to the coronavirus pandemic “materially affects the functioning of the Patent and Trademark Office,” “prejudices the rights of applicants, registrants, patent owners, or others appearing before the Office,” or prevents users from filing a document or paying a fee timely. See Section 12004.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from